Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.7200 (unch)
Fortress Biotech: Q2 Earnings Snapshot

Fortress Biotech: Q2 Earnings Snapshot

FBIO : 1.7200 (unch)
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 1.7200 (unch)
Earnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FBIO : 1.7200 (unch)
XENE : 40.67 (+1.42%)
Fulcrum Therapeutics, Inc. (FULC) Reports Q4 Loss, Misses Revenue Estimates

Fulcrum Therapeutics, Inc. (FULC) delivered earnings and revenue surprises of -2.04% and 64.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

FULC : 7.14 (+0.14%)
FBIO : 1.7200 (unch)
Fortress Biotech (FBIO) Reports Q3 Loss, Misses Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 7.41% and 13.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

FBIO : 1.7200 (unch)
VERU : 1.2500 (+3.31%)
Bellus Health (BLU) Reports Q3 Loss, Misses Revenue Estimates

Bellus (BLU) delivered earnings and revenue surprises of -11.11% and 60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BLU : 14.74 (unch)
FBIO : 1.7200 (unch)
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.7200 (unch)
Twist Bioscience (TWST) Surges 16.1%: Is This an Indication of Further Gains?

Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

TWST : 31.40 (+1.03%)
FBIO : 1.7200 (unch)
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 2.13% and 5.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SGHT : 5.23 (+1.75%)
FBIO : 1.7200 (unch)

Barchart Exclusives

Microsoft Shows Massive FCF Growth Despite High AI Spending - MSFT Looks Undervalued
Microsoft produced excellent quarterly results with higher free cash flow despite increased AI capex spending. This makes MSFT look undervalued here and provides a good opportunity for short-put investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar